0001104659-22-062438.txt : 20220518
0001104659-22-062438.hdr.sgml : 20220518
20220518160627
ACCESSION NUMBER: 0001104659-22-062438
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luo Mary Z.
CENTRAL INDEX KEY: 0001611156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 22939106
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Jack Y.
CENTRAL INDEX KEY: 0001611157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 22939107
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
tm2215971-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-16
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001611157
Zhang Jack Y.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
CEO & Chief Scientific Officer
0001611156
Luo Mary Z.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
CEO & Chief Scientific Officer
Common Stock
2022-05-16
4
S
0
54274
35.5822
D
2287740
D
Common Stock
2022-05-16
4
S
0
13795
36.4095
D
2273945
D
Common Stock
2022-05-17
4
S
0
47539
35.7371
D
2226406
D
Common Stock
2022-05-17
4
S
0
2837
36.1416
D
2223569
D
Common Stock
1498519
I
See footnote
Common Stock
6827679
I
See footnote
Common Stock
5000
I
See footnote
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.63, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.065 to $36.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.07 to $36.27, inclusive.
The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
/s/ Eva Wen, by power of attorney for Jack Y. Zhang
2022-05-18
/s/ Eva Wen, by power of attorney for Mary Z. Luo
2022-05-18